| 1 | 18701502 | Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. | Cancer Res | 2008 Aug 15 |
1 |
| 2 | 19602592 | Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. | Cancer Res | 2009 Aug 1 |
1 |
| 3 | 21060834 | Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus. | PLoS One | 2010 Oct 29 |
1 |
| 4 | 24100156 | Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7. | Bioorg Med Chem | 2013 Nov 15 |
1 |
| 5 | 24625057 | Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). | J Med Chem | 2014 Apr 10 |
1 |
| 6 | 25660273 | Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain. | Chem Biol | 2015 Feb 19 |
2 |
| 7 | 26216446 | Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment. | Naunyn Schmiedebergs Arch Pharmacol | 2015 Nov |
3 |
| 8 | 26343356 | Polycomb genes are associated with response to imatinib in chronic myeloid leukemia. | Epigenomics | 2015 Aug |
1 |
| 9 | 27291091 | Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription. | Sci Rep | 2016 Jun 13 |
3 |
| 10 | 27326334 | Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7. | ACS Med Chem Lett | 2016 Jun 9 |
5 |
| 11 | 27723458 | Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin. | Elife | 2016 Oct 10 |
1 |
| 12 | 28220557 | Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands. | J Pept Sci | 2017 Apr |
3 |
| 13 | 29073373 | Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3' UTRs to Regulate mRNA Expression. | Cell Syst | 2017 Oct 25 |
1 |
| 14 | 29190923 | Prognostic values of distinct CBX family members in breast cancer. | Oncotarget | 2017 Nov 3 |
1 |
| 15 | 29723807 | The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation. | Comput Biol Chem | 2018 Jun |
1 |
| 16 | 30023485 | Structure-Activity Relationships of Cbx7 Inhibitors, Including Selectivity Studies against Other Cbx Proteins. | ACS Omega | 2016 Oct 31 |
3 |
| 17 | 30584339 | miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression. | Onco Targets Ther | 2018 |
4 |
| 18 | 30759399 | CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions. | Cell Rep | 2019 Feb 12 |
2 |
| 19 | 31422906 | Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7. | Cell Chem Biol | 2019 Oct 17 |
1 |
| 20 | 31755685 | Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor. | ACS Chem Biol | 2020 Jan 17 |
1 |
| 21 | 32453338 | Integrated analysis of lncRNA-associated ceRNA network identified potential regulatory interactions in osteosarcoma. | Genet Mol Biol | 2020 |
1 |
| 22 | 32621571 | Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition of CBX7 protein. | Environ Toxicol | 2020 Nov |
1 |
| 23 | 34992383 | CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma. | Onco Targets Ther | 2021 |
2 |
| 24 | 35636434 | Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin. | Drug Res (Stuttg) | 2022 May 30 |
4 |